Q4/2023 12/31/2023 EPS -0.170 ZacksConsensus -0.150 ActVsEst (0.020) - Miss
Theravance Biopharma, Inc. - Ordinary Shares (TBPH)
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.theravance.com/investor-relations
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
TBPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TBPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TBPH alerts
High impacting Theravance Biopharma, Inc. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TBPH
News
- KBR Stock Soars 5%: Activist Investor Pushes for Breakup to Unlock 50% Value Surge [Yahoo! Finance]Yahoo! Finance
- Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare ConferencePR Newswire
- The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable [Yahoo! Finance]Yahoo! Finance
- Theravance Biopharma to Participate in an Upcoming Investor ConferencePR Newswire
- Kevin Krause named President and CEO of ArrePath [Yahoo! Finance]Yahoo! Finance
TBPH
Earnings
- 11/12/24 - Miss
TBPH
Sec Filings
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- TBPH's page on the SEC website